CHENGDU XENOMIX BIOTECHNOLOGY CO LTD
Overview
CHENGDU XENOMIX BIOTECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMES; NONTOXIC DIPHTHERIA TOXIN MUTANT CRM197.
API / Drug Master Files
CHENGDU XENOMIX BIOTECHNOLOGY CO LTD holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- NONTOXIC DIPHTHERIA TOXIN MUTANT CRM197Active2022-12-09
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to CHENGDU XENOMIX BIOTECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this CHENGDU XENOMIX BIOTECHNOLOGY CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.